PTC THERAPEUTICS, INC. — Director's Dealing 2015

Mar 23, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2015-03-23

Reporting Person: Peltz Stuart Walter (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-23	Common Stock	S	38725	$68.96	Disposed	8475	Direct
2015-03-23	Common Stock	S	6575	$69.79	Disposed	1900	Direct
2015-03-23	Common Stock	S	1900	$70.57	Disposed	0	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan entered into on August 14, 2014 for the primary purposes of covering tax obligations associated with a restricted stock vesting event and diversification.

F2: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $68.44 to $69.43 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F3: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $69.45 to $70.35 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F4: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $70.45 to $70.74 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.